NEW YORK and SALT LAKE CITY, April 08, 2022 (GLOBE NEWSWIRE) -- Renalytix Plc (NASDAQ:RNLX) (LSE:RENX.LN) announces that under the Company's Employee Share Purchase Plan (the "ESPP"), 22,814 new ordinary shares of £0.0025 each in the capital of the Company (the "Ordinary Shares") have been issued to settle the purchase of 11,407 American Depositary Shares, each representing two Ordinary Shares, by employees who participated in the ESPP. This was carried out at a subscription price of $7.8795 per American Depositary Share (£3.00 per Ordinary Share). Further details in relation to the ESPP were contained in the Company's announcement of 2 September 2020.
Renalytix plc Issue of shares
Globe Newswire - Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here
/amazon%20holiday%20delivery%20boxes%20by%20Cineberg%20via%20iStock.jpg)
/NVIDIA%20Corp%20logo%20on%20phone%20and%20AI%20chip-by%20Below%20the%20Sky%20via%20Shutterstock.jpg)
/Palo%20Alto%20Networks%20Inc%20HQ%20sign-by%20Tada%20Images%20via%20Shutterstock.jpg)
/Lululemon%20Athletica%20inc_%20leggings%20by-%20Sorbis%20via%20Shutterstock.jpg)